🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the reactogenicity, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-02
Trial ID
NCT05169905
Treatments Being Tested
The purpose of this Registry is to detect and describe any abnormal pregnan...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-31
Trial ID
NCT02096276
Treatments Being Tested
The purpose of this study is to determine the effectiveness of Adacel again...
Status
Completed
Location
Sanofi Pasteur
Start Date
2021-06-02
Trial ID
NCT05040802
Treatments Being Tested
The purpose of this study is to evaluate the safety, ability of GSK Biologi...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-11-05
Trial ID
NCT04138056
Treatments Being Tested
Currently, there is no 5-component acellular pertussis vaccine licensed for...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00467519
This is a dose exploration study to assess the safety and immunogenicity of...
Status
Completed
Location
Multiple Locations
Start Date
2000-11
Trial ID
NCT00729001
This study will evaluate the safety and immune response to GlaxoSmithKline ...
Status
Completed
Location
GSK Investigational Site
Start Date
2002-11
Trial ID
NCT00109330
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of t...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00355121
The purpose of this study is to evaluate the safety of Adacel vaccine among...
Status
Active Not Recruiting
Location
Investigational Site
Start Date
2024-01-02
Trial ID
NCT06258057
Treatments Being Tested
The purpose of this study was to evaluate the immunogenicity and safety of ...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00777257